SPRING BK PHARMACEUTICALS IN's ticker is SBPH and the CUSIP is 849431101. A total of 52 filers reported holding SPRING BK PHARMACEUTICALS IN in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $4,000 | -60.0% | 2,782 | 0.0% | 0.00% | -100.0% |
| Q3 2019 | $10,000 | +100.0% | 2,782 | +124.4% | 0.00% | – |
| Q2 2019 | $5,000 | -80.0% | 1,240 | -48.8% | 0.00% | -100.0% |
| Q1 2019 | $25,000 | -7.4% | 2,421 | -8.2% | 0.00% | 0.0% |
| Q4 2018 | $27,000 | -3.6% | 2,638 | +14.9% | 0.00% | 0.0% |
| Q3 2018 | $28,000 | -98.3% | 2,295 | +1563.0% | 0.00% | – |
| Q2 2018 | $1,635,000 | – | 138 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 615,384 | $8,332,000 | 1.29% |
| RTW INVESTMENTS, LP | 250,000 | $3,385,000 | 0.71% |
| Monashee Investment Management LLC | 100,000 | $1,354,000 | 0.57% |
| PARSONS CAPITAL MANAGEMENT INC/RI | 275,728 | $3,733,000 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 175,000 | $2,370,000 | 0.40% |
| TIEDEMANN ADVISORS, LLC | 362,049 | $4,902,000 | 0.36% |
| Morse Asset Management, Inc | 63,700 | $862,000 | 0.28% |
| Private Capital Advisors, Inc. | 56,250 | $762,000 | 0.25% |
| Crestline Management, LP | 98,581 | $1,335,000 | 0.18% |
| SECTORAL ASSET MANAGEMENT INC | 112,500 | $1,523,000 | 0.17% |